New diabetes clinical trial: Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)

Published on: July 02, 2019 at 07:00PM
Condition:   Type 2 Diabetes
Interventions:   Behavioral: Intensive lifestyle intervention;   Drug: Dapagliflozin 10 MG
Sponsor:   Shanghai Zhongshan Hospital
Not yet recruiting